News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Sarepta Therapeutics, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Job Trends
The Power of Three: Sarepta to Open New Plant, Hire Staff and Confirms Kaye as CEO
September 21, 2016
·
2 min read
FDA
Meet the Powerful Woman Behind the Scenes of Sarepta’s DMD Drug Approval
September 20, 2016
·
4 min read
FDA
Victory at Last! Sarepta Stock Doubles as the FDA Finally Approves DMD Drug
September 19, 2016
·
3 min read
Business
Turn the Page: Sarepta Stock Pops on Rumors DMD Drug Naysayer Leaves the FDA
September 14, 2016
·
3 min read
Biotech Beach
3 High-Risk, High-Reward Biotech Stocks
August 24, 2016
·
3 min read
Policy
Sarepta’s Duchene Muscular Dystrophy Drug: Evaluating the Placebo Effect
August 19, 2016
·
4 min read
Drug Development
Sarepta Stock Surges After Government Website Indicates Firm is Recruiting for Phase III Study
August 4, 2016
·
3 min read
Policy
Sarepta Surges Yet Again, as the FDA Requests More Data About Duchenne’s Drug
June 7, 2016
·
3 min read
Policy
All Eyes Turn to Sarepta as BioMarin Shutters Its Kyndrisa Duchenne Program
June 1, 2016
·
4 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 30, 2026
July 1, 2026
·
1 min read
Press Releases
Sarepta Announces FDA Acceptance of sNDAs for AMONDYS 45® and VYONDYS 53®
June 30, 2026
·
17 min read
Press Releases
Sarepta Therapeutics to Participate in Upcoming Investor Conferences
June 2, 2026
·
1 min read
Press Releases
Sarepta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
May 14, 2026
·
1 min read
Press Releases
Sarepta Therapeutics Announces First Quarter 2026 Financial Results and Recent Corporate Developments
May 7, 2026
·
19 min read
Press Releases
Sarepta Therapeutics to Announce First Quarter 2026 Financial Results
April 23, 2026
·
1 min read
Press Releases
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 31, 2026
April 1, 2026
·
1 min read
Press Releases
Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
March 25, 2026
·
9 min read
Press Releases
Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
March 25, 2026
·
1 min read
Press Releases
Sarepta Provides Regulatory Update on AMONDYS 45® and VYONDYS 53®
March 19, 2026
·
15 min read
